文献速递真菌感染

MucorGenius® PCR检测BALF标本对肺毛霉病的诊断准确性:前瞻性收集队列的回顾性分析

Diagnostic accuracy of Mucorales PCR testing in bronchoalveolar lavage fluid samples: a retrospective analysis of a prospectively collected cohort.
PubMed 文献 · Clin Microbiol Infect · 2026-01-27

本研究评估MucorGenius® PCR在BALF中检测肺毛霉病的诊断性能。回顾性检测1407份BALF标本,患者水平特异性98.6%,敏感性100%。PCR可识别部分可能IMI和 probable IPA 中的混合霉菌感染。

要点

  • MucorGenius® PCR在BALF中特异性98.6%,阳性结果高度提示肺毛霉病。
  • 在possible IMI和probable IPA患者中,PCR可发现可能被遗漏的混合霉菌感染。
  • 研究敏感性100%但仅基于4例确诊/临床诊断肺毛霉病,需谨慎解读。

核心结论

  • MucorGenius® PCR在BALF中检测肺毛霉病具有近于完美的特异性,阳性结果使肺毛霉病诊断极有可能。
  • 该检测能在部分possible IMI和probable IPA病例中识别毛霉感染,提示可能漏诊的混合霉菌感染。

研究设计与样本

  • 回顾性诊断准确性研究,使用前瞻性收集的连续BALF标本。
  • 共纳入1330例患者的1407份BALF标本,所有标本回顾性进行MucorGenius® PCR检测。
  • 患者按EORTC/MSGERC及adapted Invasive Fungal Diseases in Adult Patients in Intensive Care Unit定义回顾性分类。

主要发现

  • 患者水平MucorGenius® PCR特异性98.6%(95% CI: 97.8-99.2;n=1251/1269),敏感性100%(95% CI: 39.8-100;n=4/4)。
  • 常规诊断证实的肺毛霉病仅4例(0.3%),26例(2%)为proven/probable IPA,25例(1.9%)为possible IMI。
  • 25例possible IMI中6例(24%)MucorGenius® PCR阳性。
  • 19份Mucorales PCR阳性样本来自无常规诊断IMI的患者。

临床怎么用

  • 对高危患者BALF进行MucorGenius® PCR检测,阳性结果可高度支持肺毛霉病诊断。
  • 在possible IMI或probable IPA患者中考虑PCR检测以发现潜在混合毛霉感染。

局限性

  • 敏感性100%仅基于4例确诊/临床诊断肺毛霉病,置信区间宽(39.8-100)。
  • 回顾性设计,常规诊断未依赖PCR,可能存在分类偏倚。
  • 单中心研究,外推性需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the diagnostic performance, particularly specificity, of the MucorGenius® PCR assay for detecting pulmonary mucormycosis in bronchoalveolar lavage fluid (BALF) samples from at-risk patients. METHODS: This is a retrospective diagnostic accuracy study using prospectively collected BALF samples. All consecutive BALF samples obtained from patients who were considered to be at risk for invasive mould infections (IMIs) were prospectively collected. Patients were retrospectively classified according to European Organization for Research and Treatment of Cancer and Mycoses Study Group Education and Research Consortium and adapted Invasive Fungal Diseases in Adult Patients in Intensive Care Unit definitions. All samples were retrospectively tested with the MucorGenius® assay. RESULTS: A total of 1407 BALF samples obtained from 1330 patients had been included and tested for Mucorales DNA. A total of 256 patients (19.6%) fulfilled European Organization for Research and Treatment of Cancer and Mycoses Study Group Education and Research Consortium host factors and 664 (49.9%) Invasive Fungal Diseases in Adult Patients in Intensive Care Unit host factors. Proven or probable pulmonary mucormycosis was routinely diagnosed (without Mucorales PCR) in four patients (0.3%), 26 patients had proven or probable invasive pulmonary aspergillosis (IPA) (2%), and 25 (1.9%) had possible IMI. Overall, 32 positive MucorGenius® results had been observed. Per patient the MucorGenius® assay gave a specificity of 98.6% (95% CI: 97.8-99.2; n = 1251/1269) and a sensitivity of 100% (95% CI: 39.8-100; n = 4/4). Two cases with IPA were routinely diagnosed with mixed Mucorales infection and three additional IPA cases had a positive MucorGenius® PCR. In total, 5 of 26 IPA cases were therefore diagnosed with a mixed mould infection. Six of the 25 possible IMI cases (24%) also turned out positive on MucorGenius® PCR. Nineteen Mucorales PCR-positive samples had been obtained from patients without any routinely diagnosed IMI. CONCLUSIONS: We observed a near-to-perfect specificity of the MucorGenius® assay in BALF, making diagnosis of pulmonary mucormycosis very likely in patients with a positive PCR. In addition, the test was able to identify mucormycosis in a relevant proportion of cases with possible IMI and probable IPA, potentially indicating otherwise missed mixed-mould infections.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Prattes J, Dichtl K, Sedik S, et al. Diagnostic accuracy of Mucorales PCR testing in bronchoalveolar lavage fluid samples: a retrospective analysis of a prospectively collected cohort. Clin Microbiol Infect. 2026. PMID: 41610953. doi:10.1016/j.cmi.2026.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。